Suppr超能文献

双相障碍转换过程的神经生物学:综述。

The neurobiology of the switch process in bipolar disorder: a review.

机构信息

Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, Bethesda, Maryland, USA.

出版信息

J Clin Psychiatry. 2010 Nov;71(11):1488-501. doi: 10.4088/JCP.09r05259gre. Epub 2010 May 4.

Abstract

OBJECTIVE

The singular phenomenon of switching from depression to its opposite state of mania or hypomania, and vice versa, distinguishes bipolar disorder from all other psychiatric disorders. Despite the fact that it is a core aspect of the clinical presentation of bipolar disorder, the neurobiology of the switch process is still poorly understood. In this review, we summarize the clinical evidence regarding somatic interventions associated with switching, with a particular focus on the biologic underpinnings presumably involved in the switch process.

DATA SOURCES

Literature for this review was obtained through a search of the MEDLINE database (1966-2008) using the following keywords and phrases: switch, bipolar disorder, bipolar depression, antidepressant, SSRIs, tricyclic antidepressants, norepinephrine, serotonin, treatment emergent affective switch, mania, hypomania, HPA-axis, glucocorticoids, amphetamine, dopamine, and sleep deprivation.

STUDY SELECTION

All English-language, peer-reviewed, published literature, including randomized controlled studies, naturalistic and open-label studies, and case reports, were eligible for inclusion.

DATA SYNTHESIS

Converging evidence suggests that certain pharmacologic and nonpharmacologic interventions with very different mechanisms of action, such as sleep deprivation, exogenous corticosteroids, and dopaminergic agonists, can trigger mood episode switches in patients with bipolar disorder. The switch-inducing potential of antidepressants is unclear, although tricyclic antidepressants, which confer higher risk of switching than other classes of antidepressants, are a possible exception. Several neurobiological factors appear to be associated with both spontaneous and treatment-emergent mood episode switches; these include abnormalities in catecholamine levels, up-regulation of neurotrophic and neuroplastic factors, hypothalamic-pituitary-adrenal axis hyperactivity, and circadian rhythms.

CONCLUSIONS

There is a clear need to improve our understanding of the neurobiology of the switch process; research in this field would benefit from the systematic and integrated assessment of variables associated with switching.

摘要

目的

从抑郁到躁狂或轻躁狂,再从躁狂或轻躁狂到抑郁的这种转换的单一现象将双相情感障碍与所有其他精神障碍区分开来。尽管这是双相情感障碍临床表现的一个核心方面,但转换过程的神经生物学仍然知之甚少。在这篇综述中,我们总结了与转换相关的躯体干预的临床证据,特别关注可能涉及转换过程的生物学基础。

数据来源

通过在 MEDLINE 数据库(1966-2008 年)中使用以下关键词和短语搜索文献,获得了这篇综述的文献:转换、双相情感障碍、双相抑郁、抗抑郁药、SSRIs、三环类抗抑郁药、去甲肾上腺素、血清素、治疗性情感转换、躁狂、轻躁狂、HPA 轴、皮质激素、安非他命、多巴胺和睡眠剥夺。

研究选择

所有符合条件的文献均为英文同行评审出版物,包括随机对照研究、自然和开放标签研究以及病例报告。

数据综合

越来越多的证据表明,某些药理学和非药理学干预措施具有非常不同的作用机制,如睡眠剥夺、外源性皮质激素和多巴胺激动剂,可在双相情感障碍患者中引发情绪发作转换。抗抑郁药引发转换的潜力尚不清楚,尽管三环类抗抑郁药比其他类别的抗抑郁药更有可能引发转换,但它们可能是一个例外。一些神经生物学因素似乎与自发性和治疗性情绪发作转换都有关;这些因素包括儿茶酚胺水平异常、神经营养和神经可塑性因素的上调、下丘脑-垂体-肾上腺轴过度活跃和昼夜节律。

结论

显然需要更好地了解转换过程的神经生物学;该领域的研究将受益于与转换相关的变量的系统和综合评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验